GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
69.82
+1.15 (1.67%)
At close: Jun 26, 2026, 4:00 PM EDT
68.70
-1.12 (-1.60%)
After-hours: Jun 26, 2026, 7:58 PM EDT
GeneDx Holdings Revenue
GeneDx Holdings had revenue of $102.25M in the quarter ending March 31, 2026, with 17.38% growth. This brings the company's revenue in the last twelve months to $442.68M, up 34.09% year-over-year. In the year 2025, GeneDx Holdings had annual revenue of $427.54M with 39.97% growth.
Revenue (ttm)
$442.68M
Revenue Growth
+34.09%
P/S Ratio
4.68
Revenue / Employee
$340,522
Employees
1,300
Market Cap
2.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 427.54M | 122.09M | 39.97% |
| Dec 31, 2024 | 305.45M | 102.88M | 50.79% |
| Dec 31, 2023 | 202.57M | -32.13M | -13.69% |
| Dec 31, 2022 | 234.69M | 22.50M | 10.60% |
| Dec 31, 2021 | 212.20M | 32.87M | 18.33% |
| Dec 31, 2020 | 179.32M | -16.85M | -8.59% |
| Dec 31, 2019 | 196.17M | 62.83M | 47.12% |
| Dec 31, 2018 | 133.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RadNet | 2.14B |
| Sotera Health Company | 1.19B |
| NeoGenomics | 745.97M |
| OPKO Health | 581.12M |
| Veracyte | 541.74M |
| CareDx | 412.82M |
| BillionToOne | 354.54M |
| Castle Biosciences | 339.92M |
WGS News
- 3 days ago - GeneDx price target raised to $63 from $50 at Piper Sandler - TheFly
- 8 days ago - GeneDx Holdings Transcript: AGM 2026 - Transcripts
- 10 days ago - GeneDx appoints Gardner as President - TheFly
- 10 days ago - GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth - Business Wire
- 11 days ago - Investor Notice of Barrack, Rodos & Bacine Concerning Its Lawsuit Against GeneDx Holdings Corp. (WGS) - GlobeNewsWire
- 15 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in GeneDx Holdings Corp. Lawsuit - WGS - PRNewsWire
- 16 days ago - GENEDX HOLDINGS CORP. (WGS) INVESTOR ALERT Investors With Large Losses in GeneDe Holdings Corp. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 16 days ago - Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of GeneDx Holdings Corp. (WGS) - Newsfile Corp